ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    Relugolix HERO
Previous Study | Return to List | Next Study

A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03085095
Recruitment Status : Recruiting
First Posted : March 21, 2017
Last Update Posted : April 18, 2018
Sponsor:
Information provided by (Responsible Party):
Myovant Sciences GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 30, 2019
  Estimated Study Completion Date : April 30, 2020